Inhibitex to Host Conference Call to Report First Quarter Financial Results on May 13, 2010
April 30 2010 - 8:45AM
Business Wire
Inhibitex, Inc. (NASDAQ: INHX) announced today that it will host
a conference call on Thursday, May 13, 2010 at 9:00 a.m. EDT to
review the Company’s first quarter financial results and provide an
update on recent corporate developments. The Company will issue a
press release regarding its financial results on the same day,
prior to the conference call.
Webcast Information
To access the conference call, please dial (877) 407-8031
(domestic) or (201) 689-8031 (international). A replay of the call
will be available from 11:00 a.m. Eastern Time on May 13th until
June 13, 2010 at midnight. To access the replay, please dial (877)
660-6853 (domestic) or (201) 612-7415 (international) and reference
the account # 286 and the conference id # 350196. A live audio
webcast of the call and the archived webcast will be available in
the News and Events section of the Inhibitex website at
http://www.inhibitex.com.
About Inhibitex
Inhibitex, Inc., headquartered in Alpharetta, Georgia, is a
biopharmaceutical company focused on developing products to prevent
and treat serious infectious diseases. The Company’s pipeline
includes FV-100, which is in Phase II clinical development for the
treatment of shingles, and INX-189, a nucleotide polymerase
inhibitor in development for the treatment of chronic hepatitis C
infections. The Company also has additional HCV nucleotide
polymerase inhibitors in preclinical development and has licensed
the use of its proprietary MSCRAMM® protein platform to Pfizer for
the development of staphylococcal vaccines. For additional
information about the Company, please visit www.inhibitex.com.
For additional information about the Company, please visit
www.inhibitex.com.
Inhibitex, Inc. (MM) (NASDAQ:INHX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Inhibitex, Inc. (MM) (NASDAQ:INHX)
Historical Stock Chart
From Jul 2023 to Jul 2024